In Vitro Fertilization Market by Products & Services (Instruments, Reagents, Accessories, and Services), Type of Cycle (Fresh Donor IVF Cycles, Fresh Non-Donor IVF Cycles, Frozen Donor IVF Cycles, and Frozen Non-Donor IVF Cycles), End User (Fertility Clinics and Hospitals & Research Laboratories) – Global Outlook & Forecast 2021-2031
According to the deep-dive market assessment study conducted by Growth+ Reports, the global in-vitro fertilization market was pegged at ~US$ 696.1 million in 2020. The market is expected to witness a CAGR of ~10.6% from 2021 to 2031.
Factors such as the growing mean age of first-time mothers, rising infertility rates, and rising public awareness about available infertility treatment options are the factors propelling the market growth. Moreover, the increasing number of fertility clinics and launches of new and advanced product are some of the other factors playing a crucial role in driving the growth of the IVF market. However, high cost of in vitro fertilization procedures and lack of reimbursement policies in several countries are likely to hinder the market growth to a certain extent.
Infertility is one of the common issues faced by many couples worldwide. Sedentary lifestyle, rising stress levels, and increasing smoking and alcohol consumption are the factors that might cause infertility. According to World Health Organization (WHO), about 48 million couples and 186 million individuals live with infertility globally. WHO is also taking initiatives such as providing country-level technical support to member states to develop or strengthen the implementation of national fertility policies and services. Such factors have led to rising awareness among people and increasing number of IVF procedures, which in turn fueling the IVF market growth.
Government organizations, as well as private firms, are launching programs that will provide counseling and support to the patients having infertility issue. For instance, in June 2020, CCRM Fertility, a global pioneer in fertility science, research and advancement, launched two new programs ‘Assure IVF Refund and Multi-Cycle Programs’. These platforms are designed to help ease the financial burdens on infertility patients those in need of multiple in vitro fertilization (IVF) cycles. Similarly, in September 2020, Univfy Inc., an artificial intelligence (AI) company dedicated in improving fertility patients experience and their access to Assisted Reproductive Technologies such as IVF, entered into partnership with Gedeon Richter, a pharmaceutical company based in Central Eastern Europe. Through this partnership, the company will be able to provide Univfy’s AI counseling platform available to patients and fertility specialists in Europe. Such initiatives are anticipated to provide lucrative growth opportunities to the IVF market.
Companies in the IVF market are increasing focus on developing and introducing new and advanced products. For instance, in January 2019, Cooper Surgical Fertility & Genomic Solutions launched three products namely the PGTai technology platform, the ERPeak endometrial receptivity test, and ORIGIO Gradient Series. The PGTai is a technology platform for embryo selection, and ERPeak Endometrial Receptivity Test helps in identifying the optimal time for embryo transfer during an IVF cycle. ORIGIO Gradient Series are media that help in maintaining high pH to mimic in vivo physiological conditions and stimulate higher motility of sperm, high HSA, and Bicarbonate concentration to support optimal sperm function, and antioxidants to minimize ROS formation, among others.
However, high cost of in vitro fertilization procedures is the major factor hindering the market growth. Moreover, couples have to undergo multiple cycles to increase the chances of pregnancy. This further increases the overall cost of the IVF procedure. Additionally, the lack of reimbursement policies for infertility treatments is also restraining the market growth to a certain extent.
Regionally, Asia-Pacific is anticipated to grow at a higher CAGR during the forecast period. Increasing infertility rates among men and women in this region, increasing number of women suffering with PCOS, and increasing awareness regarding infertility treatment options are some of the factors driving the in vitro fertility market in the region. Moreover, rising medical tourism in countries such as India and Thailand for in vitro fertility treatment is also contributing to the growth of the market in this region. Companies are also launching various types of products in this region. For instance, in February 2019, Merck KGaA, launched infertility devices, namely Geri and Gavi, as well as Gems, a complete culture medium suite in India. These products were made available in partnership with Genea Biomedx, to IVF clinics and hospitals. Such factors are anticipated to propel the market during the forecast period.
Some of the prominent players operating in the global in vitro fertilization market include Cooper Surgical Fertility & Genomic Solutions (The Cooper Companies), Cook, Vitrolife, Fujifilm Irvine Scientific, Merck KGaA, IVFtech ApS, Limited, Rocket Medical plc., Thermo Fisher Scientific, Inc., and Esco Medical, among others.